S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML.

Authors :: Montesinos, Pau
Rodríguez-Veiga, Rebeca
Bergua Burgues, Juan Miguel
Algarra, Lorenzo
Botella, Carmen
Josè Antonio, Perez Simon
Bernal, Teresa
Tormo, Mar
Robles, Maria Calbacho
Salamero, Olga
Serrano, Josefina
Noriega, Victor
López-López, Juan Antonio
Polo, Susana Vives
Colorado, Mercedes
Lorenzo, Jose Luis Lopez
Vidriales, María Belén
Boyero, Raimundo Garcia
Olave, Mayte
Herrera-Puente, Pilar
Source :: HemaSphere; 2023 Supplement 3, Vol. 7, pe734771d-e734771d, 1p
Publication Year :: 2023

Full Text Access

Tools